Implantation of the HeartMate 3 Left Ventricular Assist Device (LVAD) — an FDA-approved mechanical heart pump for end-stage heart failure patients who are either awaiting a transplant (bridge-to-transplant) or ineligible for one (destination therapy). India's leading cardiac centers are now equipped with this technology.
One of the primary drivers for medical travel to Delhi is the dramatic price difference. Below is a realistic comparison of average cost packages for Heart Transplant – HeartMate 3 (LVAD) across global destinations:
| Country | Estimated Cost (USD) | Average Savings |
|---|---|---|
| India (Delhi-NCR) | ~$100,000 USD | Save ~60% vs US |
| United States | $250,000+ | Baseline Cost |
| United Kingdom | $180,000 | Save ~100% |
An interactive overview of what a typical clinical journey looks like in Delhi-NCR for this procedure.
Mustasfaa representative meets you and your attendant directly at Delhi-NCR Indira Gandhi Airport (DEL) holding a custom name card. We escort you to your booked hotel via private cab. FRRO visa registration is initiated if required.
Our coordinator escorts you to the partner hospital. You meet your treating specialist, review your scans, and complete pre-admission tests (blood works, ECG, chest X-rays, etc.). Admission slots and recovery pathways are formally scheduled.
You are admitted into your selected room category. The surgical team executes the Heart Transplant – HeartMate 3 (LVAD) in a highly advanced laminar-flow operating suite. Post-operative recovery is initiated in the dedicated critical care / recovery ICU wings.
Nursing teams monitor your recovery metrics, drain removals, and clinical progress. Physical therapists guide you through early mobilization and recovery activities. Discharge checklist is processed once the surgeon signs off.
You check-in back at the hotel for the recovery period (average recovery time is 3 – 6 Months). Our coordinators assist you with post-discharge follow-up checks, prescriptions, and fit-to-fly certificates, followed by airport drop-off.
The HeartMate 3 is a fully magnetically levitated centrifugal-flow LVAD. It is surgically implanted inside the chest to assist the weakened left ventricle in pumping blood. It operates continuously and the patient carries a portable controller and batteries.
India's top cardiac institutes (Fortis Escorts, Max Saket, Medanta) now have LVAD programs with trained perfusionists and cardiothoracic ICUs. The device cost is standardized worldwide, but surgical fees, ICU care, and rehabilitation in India are significantly lower than in the US or UK.
Yes. After a full in-hospital recovery of typically 14–21 days and caregiver training, most LVAD patients can return home and manage day-to-day activities independently with close telehealth follow-ups.
Enter your details to initiate chat with our AI Medical assistant.